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Introduction
Hypusine biosynthesis occurs exclusively in one cellular protein, the precursor of eukaryotic translation initiation factor eIF5A, through a unique two-step posttranslational modification. In the first step, deoxyhypusine synthase facilitates the transfer of the 4-aminobutyl moiety from spermidine to the eIF5A precursor protein containing lysine to form a deoxyhypusine-containing protein (Park et al., 1982; Park and Wolff, 1988; Wolff et al., 1990) . Subsequent hydroxylation of this intermediate by deoxyhypusine hydroxylase completes hypusine synthesis and eIF5A maturation (Abbruzzese et al., 1988) .
Disruption of any step involved in hypusine synthesis leads to arrested cell proliferation. In the yeast Saccharomyces cerevisiae, inactivation of two eIF5A genes (Schnier et al., 1991; Wöhl et al., 1993) or the deoxyhypusine synthase gene (Sasaki et al., 1996; Park et al., 1998) causes suppression of growth and eventual loss of cell viability. The growth inhibition of mammalian cells depleted of the polyamine spermidine was attributed to deprivation of mature eIF5A containing hypusine (Byers et al., 1994) . Inhibitors of deoxyhypusine synthase and/or deoxyhypusine hydroxylase exert strong antiproliferative effects in various mammalian cells, including many human cancer cell lines (Hanauske-Abel et al., 1994; Park et al., 1994; Lee et al., 1995) . As the first enzyme in the hypusine synthetic pathway, deoxyhypusine synthase occupies a critical position, and could provide a potential target for intervention in cell proliferation.
As is the case for eIF5A, the amino acid sequence of deoxyhypusine synthase is highly conserved among various eukaryotic species (Joe et al., 1995; Kang et al., 1995; Tao and Chen, 1995a; Wolff et al., 1995; Chen and Liu, 1997; Wolff and Park, 1999) ; both eIF5A and deoxyhypusine synthase also appear to be functionally conserved throughout eukaryotic evolution. Deoxyhypusine synthases from several species share similar physical and catalytic properties. Experimental evidence from gel filtration and/or ultracentrifugation studies suggests that the enzymes from rat, human, yeast (Saccharomyces cerevisiae) and Neurospora crassa exist as a homotetramer of identical subunits (Wolff et al., 1990; Joe et al., 1995; Kang et al., 1995; Tao and Chen, 1995a; 1995b; Wolff et al., 1995) . They exhibit narrow specificity toward spermidine and NAD + . The eIF5A undergoes two types of posttranslational modifications, hypusination and phosphorylation, where the activity of the factor is dependent on the first but is not influenced by the latter in vitro (Kang et al., 1993) . For the probable regulation of eIF5A activity, a reversible modification may be one of the possibilities. Deoxyhypusine synthase, the first enzyme involved in hypusination, could thus be an eligible target.
The reversible phosphorylation of proteins is a major mechanism for the regulation of a broad spectrum of fundamental cellular processes (Krebs, 1994; Hunter, 2000) . Given the importance of this covalent modification, it may not be surprising that the human genome encodes several hundred distinct protein kinases (Lander et al., 2001; Venter et al., 2001) , that a third of all cellular proteins appear to be phosphorylated (Ahn and Resing, 2001) . Accordingly, on average, each protein kinase may phosphorylate a few dozen proteins within a cell. Protein kinase CK2 (formerly known as CKII, casein kinase II) exhibits a much broader specificity and are likely to phosphorylate over 160 distinct proteins within cells (Pinna, 1990; Allende and Allende, 1995) .
On all its substrates, CK2 phosphorylates Ser/Thr residues specified by clusters of acidic residues, mostly located on the C-terminal side of the target amino acid, with the residue at position n+3 being responsible for the minimum consensus, S/T-X-X-Neg, where Neg is the negatively charged side chain of either a carboxylic residue (Glu or Asp) or a previously phosphorylated residue (Ser-P or Tyr-P) (Meggio et al., 1994a) .
Recent discovery by Park et al. (2003) exhibited the efficient reversal of deoxyhypusine synthesis when eIF5A ([ 3 H]deoxyhypusine) was incubated with human deoxyhypusine synthase, NAD, and 1,3-diaminopropane, [ 3 H] spermidine was formed. Purified human deoxyhypusine synthase also exhibited homospermidine synthase activity when incubated with spermidine, NAD, and putrescine. Thus, it was found that putrescine can replace eIF5A precursor protein as an acceptor of the 4-aminobutyl moiety of spermidine to form homospermidine (Park et al., 2003) .
Due to their sequence homology, there is no doubt that the homospermidine synthase originated from deoxyhypusine synthase by gene duplication and recruitment for pyrrolizidine alkaloid biosynthesis (Ober and Hartmann, 1999a; 2000) . The two enzymes share the same reaction mechanism, except for the loss of the ability of homospermidine synthase to bind the eIF5A precursor protein to its surface and deoxyhypusine synthase, in addition to its intrinsic activity, already catalyzes the aminobutylation of putrescine yielding homospermidine. Thus, homospermidine synthase has to be considered a deoxyhypusine synthase which lost its intrinsic activity. It provides new insights into the intricate specificity and versatility of the deoxyhypusine synthase reaction.
Lately, we demonstrated that yeast recombinant deoxyhypusine synthase was phosphorylated by PKC in vitro (Kang and Chung, 1999) . Furtheremore, deoxyhypusine synthase was found to be phosphorylated by endogenous kinases in various cell lines and shown to have close association with PKC in intact CHO cells (Kang et al., 2002) . Deoxyhypusine synthase contains putative phosphorylation sequence motifs for CK2 as well as for PKC. In this report, we presented phosphorylation modification of deoxyhypusine synthase by CK2, another Ser/Thr kinase, in vivo and in vitro, and evaluated the relationship between phosphorylation of deoxyhypusine synthase and the activity of the enzyme. [1,8- 3 H]Spermidine․HCl (15 Ci/mmol), [γ-32 P]ATP (6,000 Ci/mmol), and [γ-32 P]GTP (6,000 Ci/mmol) were obtained from NEN Life Science Products. DMEM, antibiotic-antimycotic mixture, and trypsin-EDTA were purchased from Gibco/BRL Life Technologies. FBS was from Hyclone. CK2 was from Upstate Biotechnology, protein size marker from MBI Fermentas (Lithuania), nitrocellulose and PVDF membranes from Millipore. Mouse anti-phosphothreonine monoclonal antibody, and mouse anti-CK2α monoclonal antibody were obtained from Santa Cruz Biotechnology, mouse antiphosphoserine monoclonal antibody from Abcam (UK). The luminol-enhanced chemiluminiscence (ECL) Western blotting detection kit was purchased from Amersham Pharmcia Biotech. Protein A agarose, polylysine, heparin, and poly (Glu, Tyr) 4:1 were obtained from Sigma. Cellulose thin layer chromatography (TLC) plate (without fluorescent indicator) was from Merck, and other chemicals were purchased as described in the text. Human deoxyhypusine synthase and eIF5A precursor proteins expressed in E. coli were purified from E. coli lysates after overexpression of human deoxyhypusine synthase and eIF5A cDNAs, respectively, are described (Joe et al., 1995) . Deoxyhypusine synthase protein from rat testis and its specific antibody were prepared as described .
M aterials and M ethods M aterials

C ell culture
HeLa cells, Chinese hamster ovary (CHO) cells, NIH3T3 cells, and HEK 293 cells were grown in DMEM, supplemented with 100 U/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B, and 10% (v/v) FBS in a humidified 5% CO2 incubator at 37 o C. Serum deprivation was carried out by lowering the concentration of FBS from 10% to 0.5% for the period of 24 h prior to specific treatment.
Protein kinase assays
Purified His-tagged deoxyhypusine synthase was incubated at 37 o C for 30 min in kinase buffer (20 mM Tris/HCl, pH 7.5, 10 mM magnesium acetate, 0.4 mM CaCl2, and 1 mM DTT) by CK2 with various effectors such as polylysine, heparin, and poly(Glu, Tyr) 4:1 in the presence of [γ-
32 P]ATP. The reaction was terminated by mixing with SDS sample buffer, and separated on a 10% SDS-polyacrylamide gel (Laemmli, 1970) . Radiolabeled proteins were visualized by autoradiography.
In vitro phosphorylation of deoxyhypusine synthase with HeLa cell lysate was performed by adding total cell extract with 1 µg of human recombinant deoxyhypusine synthase protein. To obtain total cellular protein, cells were washed with cold PBS and harvested with a rubber policeman, resuspended in whole cell suspension buffer (10 mM Tris/HCl, pH 7.5, and 2 mM MgCl2) and centrifuged at 2,700 g at 4 o C for 5 min. Then they were freeze-thawed, suspended in 100 µl of suspension buffer containing 1% Triton X-100, 5 mM DTT, and 1 mM PMSF, vortexed, and then stood for 10 min on ice. Cell lysates were cleared by centrifugation at 15,000 g at 4 o C for 10 min. The amount of cellular protein present in the clarified supernatant was calculated by using the Bio-Rad protein assay kit. Kinase assays using HeLa cell lysates were incubated with kinase buffer with various CK2 effectors in the presence of [γ-32 P]ATP at 37 o C for 30 min. The phosphorylated reaction mixtures were processed for immunoprecipitation.
For in vivo phosphorylation of deoxyhypusine synthase, growth-arrested HeLa cells plated onto 150-mm dishes were treated with mock or polylysine, heparin, and poly(Glu, Tyr) 4:1 for 30 min at 37 o C. After treatments, cell lysates were generated using repeated freeze-thawed cycle. The resulting cell lysates containing equal amounts of protein were used for immunoprecipitation and Western blotting.
Phosphoam ino acid analysis
Affinity purified human deoxyhypusine synthase was radiolabeled by CK2, electrophoretically separated on a 10% SDS-polyacrylamide gel and transferred to Immobilon (Millipore) (Kamps and Sefton, 1989; Duclos et al., 1991) . The subsequent 32 P-labeled deoxyhypusine synthase band was excised, transferred to screwcap microfuge tube, and hydrolyzed at 110 o C for 2 h in 6 M HCl under nitrogen gas. Hydrolysates were dried in speedvac concentrator, dissolved in distilled water, and applied to cellulose TLC plate. Phosphoamino acids were separated by chromatography in isobutyric acid/0.5 M ammonium hydroxide (5:3, v/v). Phosphoamino acid standards were visualized by ninhydrin staining while radiolabeled phosphoamino acids were detected by autoradiography.
Im m unoprecipitation and W estern blot analysis
For the immunoprecipitation experiments, 2 mg of cellular extract was incubated with polyclonal rabbit anti-deoxyhypusine synthase antibody for 2 h at 4 o C. Protein A agarose was then added to precipitate the immune complex and incubated for further 30 min at 4 o C with constant rocking. The beads were washed and the final pellets were separated by SDS-PAGE followed by Western blot analysis with appropriate indicated antibody.
For Western blotting, precipitated immunocomplexes were resolved by SDS-PAGE and transferred to nitrocellulose membrane by standard procedures (Towbin et al., 1992) . Immunoblotting was done with specific antibodies and visualized by using the ECL Western blotting detection kit (Amersham Pharmacia Biotech) with manufacturer's instructions.
Assay of deoxyhypusine synthase
The enzyme activity was measured as described previously (Wolff et al., 1990; Kang et al., 1995) . A typical reaction mixture contained, in total volume of 20 µl, 0.2 M glycine/NaOH buffer, pH 9.5, containing 1 mM DTT, 25 µg of bovine serum albumin, 1 mM NAD + , 7-9 mM (2-5 µCi) [1, H]spermidine, 10 µM human eIF5A precursor protein, and enzyme. Incubations were at 37 o C for 1 h. The radioactivity of [ 3 H]-deoxyhypusine was measured after its separation from other components of the acid hydrolyzed protein fraction by ion exchange chromatography as described previously (Wolff et al., 1990) . One unit of activity is defined as the amount of enzyme catalyzing the formation of 1 pmol of deoxyhypusine h -1 .
R esults
Deoxyhypusine synthase was phosphorylated by purified recombinant PKC [PKC (α+β+γ) mixture, and PKC δ] in vitro (Kang and Chung, 1999) , and also phosphorylated by CHO cell lysate. Furthermore, we demonstrated this enzyme was phosphorylated and associated with PKC in vivo (Kang et al., 2002) . Human deoxyhypusine synthase contains several potential phosphorylation sequence motifs for CK2, in addition to PKC. Study was extended to confirm the phosphorylation of deoxyhypusine synthase by CK2 and define its role on the regulation of eIF5A in the cell. Protein kinase CK2 is a pleiotropic Ser/Thr kinase which has been shown to phosphorylate numerous substrates. CK2 is ubiquitous in eukaryotes and its amino acid sequences are highly conserved, and the enzyme has been shown to be elevated in rapidly growing cells (Pinna, 1990) . In order to examine whether deoxyhypusine synthase could be a substrate for CK2, we analyzed the in vitro phosphorylation of human recombinant deoxyhypusine synthase by protein kinase CK2 in the presence of [γ-32 P]ATP as phosphate donor. As shown in Figure 1A , the phosphorylated deoxyhypusine synthase was clearly detectable (lower panel, lane 1). Furthermore, to confirm CK2-mediated phosphorylation in deoxyhypusine synthase, this enzyme was incubated in the presence of various CK2 effectors such as polylysine (100 nM), heparin (10 µg/ml), and poly(Glu, Tyr) 4:1 (1 mg/ml). Polylysine, CK2 activator, stimulates the phosphorylation of human deoxyhypusine synthase by CK2 in vitro. Figure 1A shows the amount of 32 P-incorporation into deoxyhypusine synthase at 100 nM polylysine resulted in 1.4-fold increase compared with that of control (lower panel, lane 2). Whereas, treatment of typical polyanionic CK2 inhibitors such as heparin and poly(Glu, Tyr) 4:1 showed 54%, and 60% radioactivity in the degree of phosphorylation, respectively, compared with mocktreated control served as 100 percent (lower panel, lane 3 and 4). This CK2-mediated phosphorylation was blocked by heparin (up to 50 µg/ml) treatment and poly(Glu, Tyr) 4:1 (up to 5 mg/ml) treatment in a dose-dependent manner (data not shown).
To verify the phosphorylation of deoxyhypusine synthase by endogenous kinases, HeLa cell lysate was allowed to incubated in kinase reaction buffer containing 1 µg of purified rat deoxyhypusine synthase and various CK2 effectors for 30 min at 37 o C in the presence of [γ- 32 P]ATP, and then immunoprecipitated with rabbit polyclonal anti-deoxyhypusine synthase antibody. The immunocomplexes bound to protein A agarose were detected by SDS-PAGE followed by autoradiography. Figure 2A shows that phosphorylated deoxyhypusine synthase appears in autoradiogram, and the levels of phosphorylation were definitely elevated with polylysine treatment (lane 2) and diminished with the treatment of heparin or poly(Glu, Tyr) 4:1 (lane 3 and 4). In order to confirm the phosphorylation of deoxyhypusine synthase by CK2, purified rat deoxyhypusine synthase was incubated with HeLa cell lysate in the presence of [γ-32 P]GTP under assay conditions as described in Figure 2A , because it has been shown that, unlike other protein kinases, CK2 can utilize GTP instead of ATP as the phosphate donor (Hathaway and Traugh, 1982) . As shown in Figure 2B , endogenous cellular kinase(s) employing GTP in HeLa cell lysate clearly phosphorylated deoxyhypusine synthase. Phosphoamino acid analysis of human deoxyhypusine synthase phosphorylated by CK2 demonstrated that this protein was phosphorylated Figure 1 . In vitro phosphorylation of human recombinant deoxyhypusine synthase by CK2. Human recombinant deoxyhypusine synthase (DHS) was incubated at 37 o C for 30 min with CK2 and various effectors such as polylysine (100 nM), heparin (10 µg/ml), and poly-(Glu, Tyr) 4:1 (1 mg/ml) in the presence of [γ-32 P]ATP. Phosphorylated deoxyhypusine synthase with a molecular mass of 41 kDa was visualized by SDS-PAGE followed by autoradiography (A). (B) Histogram depiction of the relative levels of phosphorylation of deoxyhypusine synthase in the absence of effector served as 100 percent control.
Relative levels of phosphorylation 1 2 3 4 mainly on threonine, and much less amount of 32 P-incorporation into serine was apparent. But there was no detectable spot on tyrosine residue on TLC plate (Figure 3 ). To determine whether deoxyhypusine synthase is phosphorylated in vivo, HeLa cells treated with various stimuli were harvested, immunoprecipitated with anti-deoxyhypusine synthase antibody, and then the immunocomplexes were resolved in SDS-gel and immunoblotted with anti-phosphothreonine or anti-phosphoserine antibody. Figure 4 demonstrated phosphorylated deoxyhypusine synthase was distinctively visible (lane 1 of A and B) and markedly increased after the addition of polylysine (lane 2). Heparin or poly (Glu, Tyr) treatment in intact HeLa cells resulted in considerable reduction in the degree of phosphorylated deoxyhypusine synthase (lane 3 and 4). The immunoreactivity of anti-phosphothreonine antibody to deoxyhypusine synthase is notably strong compared with that of anti-phosphoserine antibody to the protein in equal titer. This is a good agreement with the result of previous phosphoamino acid analysis (Figure 3) .
To strengthen that CK2 present in cell lysates is directly involved in the phosphorylation of deoxyhypusine synthase, we searched for an association between CK2α and deoxyhypusine synthase in vitro. As shown in Figure 5A , there is a definite interaction between deoxyhypusine synthase and CK2α, and the highest level of CK2α subunit was observed in HeLa and HEK 293 cells, followed by CHO and NIH3T3 cells. To further confirm that CK2 is directly implicated in deoxyhypusine synthase phosphorylation, we examined for an in vivo association. Figure 5B shows deoxyhypusine synthase could be closely correlated with CK2α in various eukaryotic cells, and this interaction was nearly equivalent in all cell lines examined.
To evaluate intracellular role of deoxyhypusine synthase phosphorylation, the enzyme was tested for the possible alteration of deoxyhypusine synthase activity during the phosphorylation processes by CK2, PKC, and HeLa cell lysate. Table 1 suggests that there was no observable changes in enzyme activity between the phosphorylated and unphosphorylated forms of deoxyhypusine synthase. 32 P-labeled deoxyhypusine synthase by CK2 was separated by SDS-PAGE, and transferred to Immobilon membrane. The membrane piece corresponding to deoxyhypusine synthase was hydrolyzed under vacuum in 6 M HCl at 110 o C for 2 h and dried in speedvac concentrator. Dried sample was subjected to thin layer chromatography in isobutyric acid/0.5 M ammonium hydroxide (5:3).
32 P-lableled phosphoamino acids were detected by autoradiography. Standard phosphoamino acids were visualized by ninhydrin staining. 
D iscussion
Deoxyhypusine is a modified lysine. It is formed posttranslationally in eukaryotic initiation factor eIF5A by deoxyhypusine synthase, employing spermidine as butylamine donor. Subsequent hydroxylation of this deoxyhypusine-containing intermediate completes the maturation of eIF5A (Park et al., 1993a; 1993b) . Hypusine-modified eIF5A, the active form of the protein, is the only cellular protein known to contain hypusine, and this modification is essential for eIF5A activity (Park et al., 1993a) . Despite of eIF5A being a constitutive component, for maintaining a homeostasis of cell, there should be some point of regulating its production due to this protein's function as one of the translation initiation factors involved in the synthesis of other cellular proteins. The most predictable target for reversible regulation of eIF5A is deoxyhypusine synthase, the first enzyme involved in its hypusination. Yeast recombinant deoxyhypusine synthase was phosphorylated with CK2 as well as PKC in vitro (Kang and Chung, 1999) . In previous report, we observed deoxyhypusine synthase was phosphorylated by PKC in vitro and the association of deoxyhypusine synthase with PKC in CHO cells was PMA-, and Ca 2+ /phospholipid-dependent (Kang et al., 2002) . The study was extended on the phosphorylation of deoxyhypusine synthase by CK2 to characterize its cellular role on the regulation of eIF5A.
Protein kinase CK2 is an ubiquitously expressed pleiotropic and probably constitutively active serine and/or threonine kinase that can use ATP as well as GTP as cosubstrate. In many organisms, protein kinase CK2 is a heterotetramer composed of two catalytic α-or α'-subunits and two regulatory β-subunits (Pinna, 1990; Allende and Allende, 1995) . CK2β seems to play at least a trifunctional role: it confers stability to the holoenzyme (Meggio et al., 1992) , it increases enzyme activity and its activity is stimulated by polycations (Grankowski et al., 1991) , and it determines substrate specificity (Bidwai et al., 1992; Meggio et al., 1992) . The catalytic α-subunit is regulated not only by the β-subunit but also by polyanions; very little is known about the α'-subunit.
Treatment with polylysine specifically increased (1.4-fold) the relative phosphorylation of deoxyhypusine synthase in human, supporting CK2 was implicated in the control of this system. The basal activity of the CK2 holoenzyme is even high in this phosphorylation reaction concerning human recombinant deoxyhypusine synthase ( Figure 1A ). There are a few notable exceptions, however, exemplified by calmodulin, where the β subunit has been shown to display a predominantly negative function. It has been suggested that the phosphorylation of these substrates either is catalyzed by intracellular pools of free catalytic subunits or is triggered by basic polypeptides, as it is known that polylysine counteracts the inhibitory effect of the β subunit (Meggio et al., 1994b) . Polyanionic heparin and poly(Glu, Tyr) 4:1, the CK2 specific inhibitors, reduce the phosphorylation of deoxyhypusine synthase by about 50-60%, indicating that CK2 is involved in deoxyhypusine synthase signaling mechanism ( Figure 1A and B) .
The in vitro phosphorylation of deoxyhypusine synthase by recombinant CK2 elicited us to investigate the phosphorylation of deoxyhypusine synthase with endogenous kinases. As shown in Figure 2A , HeLa cell lysates induced the phosphorylation of deoxyhypusine synthase and the degree of phosphorylation by the cell lysate was influenced by the treatment of polylysine, heparin, or poly(Glu, Tyr) in the same manner of Figure 1 . In addition, the phosphorylation of deoxyhypusine synthase by cell lysate was also detected in the presence of GTP as the phosphate donor, suggesting involvement of CK2 in this pathway. Phosphoamino acid analysis of human recombinant deoxyhypusine synthase phosphorylated by CK2 revealed that this enzyme was phosphorylated on threonine by about 70% of the total phosphorylation and the remainder of the phosphorylation on serine. Deoxyhypusine synthase is indeed Ser/Thr phosphorylated in intact HeLa cells. Such a phosphorylation is especially increased if HeLa cells are incubated with polylysine ( Figure 4) . It is also detectable, however, in untreated cells. Such an in vivo phosphorylation is markedly decreased by specific inhibitor of CK2, heparin and poly(Glu, Tyr). On the basis of these results, it could be possible to suggest that CK2 might be the in vivo kinase in the phosphorylation of deoxyhypusine synthase.
To confirm our in vitro data, the association of CK2 with deoxyhypusine synthase was examined in various cells, that is, HeLa, CHO, NIH3T3, and HEK 293 cells. The fact that deoxyhypusine synthase and CK2α subunit can be co-immunoprecipitated from different cells, clearly support the specificity of association as well as possible cellular signal link. Based on the results showing different intensities in the association of CK2α with deoxyhypusine synthase between the in vitro ( Figure 5A ) and in vivo ( Figure 5B ), one could speculate that a signaling mechanism turning off the stimulation of deoxyhypusine synthase by CK2 other than the direct molecular interaction between the two proteins presents in intact cells.
Deoxyhypusine synthase is definitively phosphorylated by CK2 in vivo. However, intracellular role of phosphorylation of this enzyme is still unclear. Unexpectedly, there was no clear differences of enzymatic activity in hypusination between phosphorylated and unphosphorylated forms of deoxyhypusine synthase (Table 1) . Deoxyhypusine synthase, as well as eIF5A, is ubiquitous in all eukaryotes, and both are essential for eukaryotic cell proliferation and survival. The vital role of this enzyme and the hypusine modification has been demonstrated from gene disruption studies in yeast (Park et al., 1998) . It was not known whether deoxyhypusine synthase can catalyze other reaction in polyamine metabolism or perform other cellular functions. Indeed, deoxyhypusine synthase is involved in the posttranslational activation of the eIF5A and, as a side-reaction, catalyzes the formation of homospermidine if its substrate, the eIF5A precursor protein, is replaced by putrescine in tobacco (Ober and Hartmann, 1999b) and senecio vernalis (Ober and Hartmann, 1999a; Ober et al., 2003) . Another plant enzyme, homospermidine synthase, which can also catalyze the synthesis of homospermidine, was identified (Ober and Hartmann, 1999a) in the roots of certain plants that produce pyrrolizidine alkaloids. Plant homospermidine synthase is assumed to be phylogenetically derived from deoxyhypusine synthase; it represents a deoxyhypusine synthase having lost its intrinsic activity. The synthesis of homospermidine as an enzymatic by-product of an essential enzyme is considered in respect to the evolutionary origin of homospermidine synthase and the biosynthetic pathway of pyrrolizidine alkaloids. Besides its established function in hypusine modification, and a proposed role in the production of homospermidine and unusual polyamines in a few mammalian tissues, deoxyhypusine synthase may have other indenpendent cellular func-tions.
Although the phosphorylation of deoxyhypusine synthase does not influence on the activity of the enzyme in hypusination reaction involving eIF5A substrate, it may implicate other cellular functions because of diverse and versatile roles of deoxyhypusine synthase. Lately, the deoxyhypusine synthase gene has been reported as one of the eight upregulated gene signature associated with metastasis in human cancer (Ramaswamy et al., 2003) . Cellular functions of deoxyhypusine synthase and the significance of phosphorylation of the enzyme in cells have to be studied in detail.
